CARF Cancer Rehabilitation Accreditation: Frequently Asked Questions
Last updated: October 2026
Expert answers to the questions oncology rehabilitation programs ask most when preparing for CARF Cancer Rehabilitation accreditation. IHS is a specialized healthcare accreditation consulting firm led by Thomas G. Goddard, JD, PhD, former COO and General Counsel of URAC.
Frequently Asked Questions
What is CARF Cancer Rehabilitation accreditation?
A specialty credential within CARF's Medical Rehabilitation Standards recognizing programs addressing the functional, physical, and psychosocial impact of cancer and treatment. Accredited programs serve survivors from diagnosis through long-term survivorship — addressing fatigue, deconditioning, lymphedema, neuropathy, cognitive dysfunction, pain, and psychological distress.
What programs qualify?
Cancer center-based rehabilitation services, outpatient oncology rehabilitation clinics, breast cancer rehabilitation programs, head and neck cancer rehabilitation programs, IRFs with cancer-specific tracks, and prehabilitation programs. Programs must deliver interdisciplinary rehabilitation addressing cancer treatment sequelae.
Does CARF require survivorship care plans?
CARF's published description of its cancer rehabilitation specialty program does not name survivorship care plans (CARF, 2026 Medical Rehabilitation Program Descriptions, page opened October 4, 2026). IHS can help a program build individualized plans with the person served, covering functional goals, ongoing rehabilitation needs, late effects monitoring and coordination with the oncology and primary care teams, and share them with other treating providers.
Does CARF name fatigue assessment tools?
Not in CARF's published description of its cancer rehabilitation specialty program, which names no fatigue tools (CARF, 2026 Medical Rehabilitation Program Descriptions, page opened October 4, 2026). IHS can help a program screen at set intervals with a validated tool, such as the FACIT-Fatigue scale or the Brief Fatigue Inventory, track the results over time and carry them into the rehabilitation plan.
Which outcome measures fit a cancer rehabilitation program?
CARF's description asks the program to track performance indicators on how effective its services are and names no instruments (CARF, 2026 Medical Rehabilitation Program Descriptions, page opened October 4, 2026). IHS can suggest a set matched to the population, such as the FACT-G or EORTC QLQ-C30 for quality of life, the 6-Minute Walk Test or PROMIS Physical Function, and lymphedema, pain and cognitive screening measures.
How should a program document oncology coordination?
CARF's description has the program coordinate care with other healthcare providers (CARF, 2026 Medical Rehabilitation Program Descriptions, page opened October 4, 2026). IHS documents that coordination through notes to oncologists on functional status and progress, rehabilitation timing set around treatment, recorded treatment precautions (bone metastases, neutropenia, thrombocytopenia, DVT risk) and joint care planning for complex cases.
How much does accreditation cost?
CARF gives a survey fee estimate when asked, and the fee turns on the surveyor count and survey length (CARF, Steps to accreditation, page opened October 4, 2026).
How long does the process take?
12 to 18 months. Programs with existing survivorship infrastructure move faster. IHS plans several months of use under the new systems before the survey. The CARF pages we reviewed set no minimum period (CARF, Accreditation decisions, page opened October 4, 2026).
What are the most common deficiencies?
Gaps a readiness review checks for: (1) Survivorship care plans absent or not systematic. (2) Fatigue screening not done with a validated tool. (3) Outcome measures not matched to the cancer population. (4) Oncology coordination informal and undocumented. (5) No lymphedema screening for at-risk populations.
Does CARF require lymphedema protocols?
CARF's published description of its cancer rehabilitation specialty program does not name lymphedema protocols (CARF, 2026 Medical Rehabilitation Program Descriptions, page opened October 4, 2026). For programs serving breast, gynecologic, or head and neck cancer populations, IHS can set up systematic screening, access to certified lymphedema therapists and lymphedema treatment within the rehabilitation plan when indicated.
How does this relate to CoC accreditation?
A cancer center that also holds or seeks Commission on Cancer accreditation can plan its rehabilitation documentation so it serves both reviews. IHS confirms each body's current requirements with the client during the gap assessment.
Does CARF name psychosocial screening tools?
CARF's published description of the cancer rehabilitation specialty program does not name screening tools (CARF, 2026 Medical Rehabilitation Program Descriptions, page opened October 3, 2026). Its standards are in the Medical Rehabilitation Standards Manual, which CARF sells. IHS can help a program screen with validated tools, such as the PHQ-9, GAD-7 or the NCCN Distress Thermometer, document access to psychological services when a screen is positive, and carry the results into the rehabilitation plan.
Does accreditation apply to prehabilitation programs?
Yes. CARF's description has the program serve people from the time of diagnosis (CARF, 2026 Medical Rehabilitation Program Descriptions, page opened October 4, 2026), so a prehabilitation program providing pre-treatment functional optimization should ask CARF whether it fits the description before applying. IHS builds survivorship care planning, oncology coordination and exercise-based optimization into the pre-treatment phase.
How does this differ from general Medical Rehabilitation accreditation?
General CARF Medical Rehabilitation covers broad populations. CARF's published description of the Cancer Rehabilitation specialty program centers on an interdisciplinary team, evidence-based practice and performance indicators for service effectiveness. IHS readiness work adds survivorship care planning, cancer fatigue protocols, outcome measurement, oncology team coordination with precaution documentation, and lymphedema protocols. Programs can hold both credentials simultaneously.
How does IHS structure cancer rehabilitation engagements?
Five phases: (1) Gap Assessment including survivorship, fatigue, outcome measurement, oncology coordination, lymphedema. (2) Policy and System Architecture. (3) Implementation and data collection launch. (4) Mock Survey with full specialty review. (5) Final Preparation. Led personally by Thomas G. Goddard, JD, PhD.